Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors.

Journal of clinical medicine(2023)

引用 1|浏览12
暂无评分
摘要
Early irAEs, especially cutaneous irAEs, correlated with a better clinical outcome in patients treated with ICIs.
更多
查看译文
关键词
efficacy,immune checkpoint inhibitors,immune-related adverse events,meta-analysis,tumor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要